Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane Sedation for Awake Fiberoptic Intubation
NCT06601036Recruiting
- Sponsor
- Tanta University
- Start
- Sep 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of sevoflurane in difficult airway (2 arms), sponsored by Tanta University. Primary endpoint: Degree of patient satisfaction. Started Sep 2024; status: recruiting.
02
Drugs
sevoflurane
03
Conditions
difficult airway
Beyond the preview
Go deeper on NCT06601036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06601036.